Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke
Part of paid clinical trials in West Orange, New Jersey.
- Sponsor
- Kessler Foundation
- Study ID
- NCT07113041
- Status
- Recruiting
Conditions
- Balance Deficits
- Stroke
- Stroke (CVA) or Transient Ischemic Attack
- Stroke Gait Rehabilitation
- Stroke Ischemic
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Combined (Robotic balance training and high-definition transcranial direct current stimulation) — DEVICEThe robotic platform will train the participants to maintain dynamic balance in the sagittal and transverse planes (mediolateral and anterior-posterior directions) and engage in core stability and trunk control with seated balance exercises. In addition, high-definition transcranial direct current stimulation (HD-tDCS) will be used as an adjuvant to robotic balance training by priming the corticospinal circuits.
- Standard of Care Balance Training — OTHERParticipants in this group will receive a standard-of-care balance training (dose matched to the experimental group) administered by the Physical therapist.
Study Details
Our proposed study, "NEUROBALANCE Stroke,"; aims to evaluate the effectiveness of a combined intervention involving robotic balance training and noninvasive brain stimulation in improving balance function and postural control in individuals with chronic stroke. The study will recruit 45 participants who have had a stroke at least 6 months before enrolment and experience persistent balance and gait deficits. Participants will be randomized into three groups: (1) robotic balance training with active brain stimulation, (2) robotic balance training with sham brain stimulation, and (3) standard-of-care rehabilitation. The study will involve 15 training sessions over 5 weeks, with assessments conducted at baseline, post-training, and two months post-training to evaluate balance recovery and retention. The primary focus is understanding how this intervention affects brain and muscle activity during balance tasks and how these changes translate into functional improvements in clinical outcome measures of balance function. Additionally, participant feedback on brain stimulation and exercise engagement will be collected to inform future studies. The findings may guide the development of personalized training protocols and contribute to broader rehabilitation strategies.
Key Dates
- Start date
- Jun 1, 2025
- Status verified
- Aug 2025
- Primary completion
- Dec 31, 2028
- Completion
- Aug 31, 2029
Study Design
- Enrollment
- 45 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: RBT + Active HD-tDCS GroupParticipants will engage in balance and postural control training on a robotic balance platform called Hunova (Movendo, Italy). Before balance training, the current intensity of 2 mA will be delivered to the leg motor area identified using individual MRI-guided neuronavigated transcranial magnetic stimulation (nTMS), and the stimulation will be turned ON for 20 minutes.
- Sham Comparator: RBT + Sham HD-tDCS GroupParticipants will engage in balance and postural control training on a robotic balance platform called Hunova (Movendo, Italy). Before balance training, the current intensity of 2 mA will be delivered to the leg motor area identified using individual MRI-guided neuronavigated transcranial magnetic stimulation (nTMS), and the stimulation will be turned ON transiently for 30 s to provide a sensation of stimulation.
- Other: SOC Control GroupThe standard of care (SOC) control group participants will perform dose-matched conventional physical therapy exercises delivered by a trained PT.
Primary Outcome Measure
Berg Balance Scale (BBS) [ Time Frame: Baseline, post 5-week training, 2-month follow-up ]
Central Contacts
- Vikram Shenoy Handiru, PhD9733243578
- Kathleen Goworek, B.S.
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Kessler Foundation | West Orange | New Jersey | 07052 |
Find similar trials in West Orange, NJ
Related Studies
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Neurofeedback Intervention for Reading Deficits in Subacute StrokeRecruiting · Kessler Foundation · West Orange, New Jersey
- Stroke Thrombectomy and Aneurysm RegistryRecruiting · Medical University of South Carolina · Birmingham, Alabama